RESUMO
There is an immediate need to optimize cardiovascular (CV) risk management and primary prevention of childhood obesity to timely and more effectively combat the health hazard and socioeconomic burden of CV disease from childhood development to adulthood manifestation. Optimizing screening programs and risk management strategies for obesity-related CV risk in childhood has high potential to change disease trajectories into adulthood. Building on a holistic view on the aetiology of childhood obesity, this document reviews current concepts in primary prevention and risk management strategies by lifestyle interventions. As an additional objective, this scientific statement addresses the high potential for reversibility of CV risk in childhood and comments on the use of modern surrogate markers beyond monitoring weight and body composition. This scientific statement also highlights the clinical importance of quantifying CV risk trajectories and discusses the remaining research gaps and challenges to better promote childhood health in a population-based approach. Finally, this document provides an overview on the lessons to be learned from the presented evidence and identifies key barriers to be targeted by researchers, clinicians, and policymakers to put into practice more effective primary prevention strategies for childhood obesity early in life to combat the burden of CV disease later in life.
Assuntos
Cardiologia , Doenças Cardiovasculares , Obesidade Infantil , Criança , Humanos , Obesidade Infantil/diagnóstico , Obesidade Infantil/epidemiologia , Obesidade Infantil/prevenção & controle , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Fatores de Risco , Estilo de Vida , Fatores de Risco de Doenças CardíacasRESUMO
Cardiac sequelae after COVID-19 have been described in athletes, prompting the need to establish a return-to-play (RTP) protocol to guarantee a safe return to sports practice. Sports participation is strongly associated with multiple short- and long-term health benefits in children and adolescents and plays a crucial role in counteracting the psychological and physical effects of the current pandemic. Therefore, RTP protocols should be balanced to promote safe sports practice, particularly after an asymptomatic SARS-CoV-2 infection that represents the common manifestation in children. The present consensus document aims to summarize the current evidence on the cardiac sequelae of COVID-19 in children and young athletes, providing key messages for conducting the RTP protocol in paediatric athletes to promote a safe sports practice during the COVID-19 era.
Assuntos
COVID-19 , Cardiologia , Cardiopatias , Medicina Esportiva , Criança , Adolescente , Humanos , Volta ao Esporte , Medicina Esportiva/métodos , SARS-CoV-2 , AtletasRESUMO
The coronavirus-19 disease (COVID-19) related pandemic have deeply impacted human health, economy, psychology and sociality. Possible serious cardiac involvement in the infection has been described, raising doubts about complete healing after the disease in many clinical settings. Moreover, there is the suspicion that the vaccines, especially those based on mRNA technology, can induce myopericarditis. Myocarditis or pericarditis related scars can represent the substrate for lifethreatening arrhythmias, triggered by physical activity. A crucial point is how to evaluate an athlete after a Covid-19 infection ensuring a safe return to play without increasing the number of unnecessary disqualifications from sports competitions. The lack of conclusive scientific data significantly increases the difficulty to propose recommendations and guidelines on this topic. At the same time, the psychological and physical negative consequences of unnecessary sports restriction must be taken into account. The present document aims to provide an updated brief review of the current knowledge about the COVID-19 cardiac involvement and how to recognize it and to offer a roadmap for the management of the athletes after a Covid-19 infections, including subsequent impact on exercise recommendations. Our document exclusively refers to cardiovascular implications of the disease, but pulmonary consequences are also considered.
RESUMO
Molecular genetic testing is an increasingly available test to support the clinical diagnosis of inherited cardiovascular diseases through identification of pathogenic gene variants and to make a preclinical genetic diagnosis among proband's family members (so-called "cascade family screening"). In athletes, the added value of molecular genetic testing is to assist in discriminating between physiological adaptive changes of the athlete's heart and inherited cardiovascular diseases, in the presence of overlapping phenotypic features such as ECG changes, imaging abnormalities or arrhythmias ("grey zone"). Additional benefits of molecular genetic testing in the athlete include the potential impact on the disease risk stratification and the implications for eligibility to competitive sports. This position statement of the Italian Society of Sports Cardiology aims to guide general sports medical physicians and sports cardiologists on clinical decision as why and when to perform a molecular genetic testing in the athlete, highlighting strengths and weaknesses for each inherited cardiovascular disease at-risk of sudden cardiac death during sport. The importance of early (preclinical) diagnosis to prevent the negative effects of exercise on phenotypic expression, disease progression and worsening of the arrhythmogenic substrate is also addressed.
Assuntos
Cardiologia , Esportes , Arritmias Cardíacas , Atletas , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia , Humanos , Biologia Molecular , Esportes/fisiologiaRESUMO
Treatment of hypertension and its complications remains a major ongoing health care challenge. Around 25% of heart attacks in Europe are already attributed to hypertension and by 2025 up to 60% of the population will have hypertension. Physical inactivity has contributed to the rising prevalence of hypertension, but patients who exercise or engage in physical activity reduce their risk of stroke, myocardial infarction, and cardiovascular mortality. Hence, current international guidelines on cardiovascular disease prevention provide generic advice to increase aerobic activity, but physiological responses differ with blood pressure (BP) level, and greater reductions in BP across a population may be achievable with more personalized advice. We performed a systematic review of meta-analyses to determine whether there was sufficient evidence for a scientific Consensus Document reporting how exercise prescription could be personalized for BP control. The document discusses the findings of 34 meta-analyses on BP-lowering effects of aerobic endurance training, dynamic resistance training as well as isometric resistance training in patients with hypertension, high-normal, and individuals with normal BP. As a main finding, there was sufficient evidence from the meta-review, based on the estimated range of exercise-induced BP reduction, the number of randomized controlled trials, and the quality score, to propose that type of exercise can be prescribed according to initial BP level, although considerable research gaps remain. Therefore, this evidence-based Consensus Document proposes further work to encourage and develop more frequent use of personalized exercise prescription to optimize lifestyle interventions for the prevention and treatment of hypertension.
Assuntos
Cardiologia , Hipertensão , Pressão Sanguínea , Consenso , Humanos , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Hipertensão/prevenção & controle , PrescriçõesRESUMO
BACKGROUND: Tobacco use is the single largest preventable risk factor for premature death of non-communicable diseases and the second leading cause of cardiovascular disease. In response to the harmful effects of tobacco smoking, the use of electronic cigarettes (e-cigarettes) has emerged and gained significant popularity over the past 15 years. E-cigarettes are promoted as safe alternatives for traditional tobacco smoking and are often suggested as a way to reduce or quit smoking. However, evidence suggests they are not harmless. DISCUSSION: The rapid evolution of the e-cigarette market has outpaced the legislator's regulatory capacity, leading to mixed regulations. The increasing use of e-cigarettes in adolescents and young individuals is of concern. While the long-term direct cardiovascular effects of e-cigarettes remain largely unknown, the existing evidence suggests that the e-cigarette should not be regarded as a cardiovascular safe product. The contribution of e-cigarette use to reducing conventional cigarette use and smoking cessation is complex, and the impact of e-cigarette use on long-term cessation lacks sufficient evidence. CONCLUSION: This position paper describes the evidence regarding the prevalence of e-cigarette smoking, uptake of e-cigarettes in the young, related legislations, cardiovascular effects of e-cigarettes and the impact of e-cigarettes on smoking cessation. Knowledge gaps in the field are also highlighted. The recommendations from the population science and public health section of the European Association of Preventive Cardiology are presented.
Assuntos
Cardiologia , Doenças Cardiovasculares , Fumar Cigarros , Sistemas Eletrônicos de Liberação de Nicotina , Abandono do Hábito de Fumar , Adolescente , Humanos , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/prevenção & controleRESUMO
European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint Task Force. Given the amount of new information that has become available since then, components from the task force and experts from the European Association of Preventive Cardiology of the European Society of Cardiology were invited to provide a summary and critical review of the most important new studies and evidence since the latest guidelines were published. The structure of the document follows that of the previous document and has six parts: Introduction (epidemiology and cost effectiveness); Cardiovascular risk; How to intervene at the population level; How to intervene at the individual level; Disease-specific interventions; and Settings: where to intervene? In fact, in keeping with the guidelines, greater emphasis has been put on a population-based approach and on disease-specific interventions, avoiding re-interpretation of information already and previously considered. Finally, the presence of several gaps in the knowledge is highlighted.
Assuntos
Cardiologia/normas , Doenças Cardiovasculares/prevenção & controle , Serviços Preventivos de Saúde/normas , Cardiologia/economia , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/economia , Doenças Cardiovasculares/epidemiologia , Consenso , Análise Custo-Benefício , Custos de Cuidados de Saúde , Fatores de Risco de Doenças Cardíacas , Humanos , Serviços Preventivos de Saúde/economia , Prognóstico , Fatores de Proteção , Medição de RiscoAssuntos
Cardiologia , Doenças Cardiovasculares/prevenção & controle , Índice de Massa Corporal , Cardiologia/normas , Atenção à Saúde/normas , Diabetes Mellitus Tipo 2/prevenção & controle , Europa (Continente) , Humanos , Hipercolesterolemia/prevenção & controle , Hipertensão/prevenção & controle , Obesidade/prevenção & controle , Medição de Risco , Fatores de Risco , Fumar/efeitos adversos , Prevenção do Hábito de Fumar , Sociedades MédicasAssuntos
Técnicas de Imagem Cardíaca/normas , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia/normas , Nível de Saúde , Aptidão Física , Medicina Esportiva/normas , Causas de Morte , Morte Súbita Cardíaca/epidemiologia , Predisposição Genética para Doença , Humanos , Incidência , Valor Preditivo dos Testes , Prognóstico , Medição de Risco , Fatores de RiscoAssuntos
Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/terapia , Atletas , Técnicas de Imagem Cardíaca/normas , Cardiologia/normas , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia/normas , Medicina Baseada em Evidências/normas , Arritmias Cardíacas/complicações , Arritmias Cardíacas/mortalidade , Consenso , Morte Súbita Cardíaca/etiologia , Humanos , Valor Preditivo dos Testes , Prognóstico , Medição de Risco , Fatores de RiscoAssuntos
Reabilitação Cardíaca/métodos , Doenças Cardiovasculares/prevenção & controle , Adulto , Fatores Etários , Idoso , Anti-Hipertensivos/uso terapêutico , Biomarcadores/metabolismo , Reabilitação Cardíaca/economia , Doenças Cardiovasculares/economia , Doenças Cardiovasculares/etnologia , Análise Custo-Benefício , Angiopatias Diabéticas/prevenção & controle , Diagnóstico por Imagem/métodos , Dieta Saudável , Exercício Físico/fisiologia , Medicina Geral/métodos , Promoção da Saúde/métodos , Estilo de Vida Saudável , Humanos , Hiperlipidemias/prevenção & controle , Hipertensão , Pessoa de Meia-Idade , Múltiplas Afecções Crônicas , Linhagem , Padrões de Prática Médica/normas , Medição de Risco , Fatores Sexuais , Abandono do Hábito de Fumar , Fatores SocioeconômicosRESUMO
This study aimed to investigate the effects of immediate postgame recovery interventions (seated rest, supine electrostimulation, low-intensity land exercises, and water exercises) on anaerobic performance (countermovement jump [CMJ], bounce jumping, 10-m sprint), hormones (salivary cortisol, urinary catecholamines), and subjective ratings (rate of perceived exertion [RPE], leg muscle pain, Questionnaire of Recovery Stress for Athletes [RestQ Sport], 10-point Likert scale), and hours of sleep of futsal players. Heart rate (HR), blood lactate, and RPE were used to evaluate the intensity of 4 futsal games in 10 players using a crossover design (P < 0.05), randomly allocating athletes to 1 of the 4 recovery interventions at the end of each game. No significant difference emerged between HR, blood lactate, RPE, and level of hydration of the games. A significant difference (P < 0.001) between games emerged for total urinary catecholamines, with an increase from the first to the second game and a gradual reduction up to the fourth game. After the game, significant reductions in CMJ (P < 0.001) and 10-m sprints (P < 0.05) emerged. No significant difference was found between recovery interventions for anaerobic performances, hormones, muscle pain, and RestQ Sport. Even though a well-balanced diet, rehydration, and controlled lifestyle might represent a sufficient recovery intervention in young elite athletes, the players perceived significantly increased benefit (P < 0.01) from the electrostimulation (7.8 +/- 1.4 points) and water exercises (7.6 +/- 2.1 points) compared to dry exercises (6.6 +/- 1.8 points) and seated rest (5.2 +/- 0.8 points.), which might improve their attitude toward playing. To induce progressive hormonal adaptation to the high exercise load of multiple games, in the last 2 weeks of the preseason, coaches should organize friendly games at a level similar to that of the competitive season.